Matching geography
Reports matching your search in:
 
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 
Region: All Regions > Africa
Category: All Categories > Life Sciences > Healthcare
(157 reports matching your criteria)
< prev 1    3  4  5  6  7  
Pharmaceuticals and Healthcare Report - South Africa - Q3 2014
7/23/2014 | published by: Business Monitor International
... and poised for high single-digitgrowth over the next decade. Headline Expenditure Projections Pharmaceuticals: ZAR34.01bn (USD3.52bn) in 2013 to ZAR37.53bn (USD3.51bn) in 2014; +10.3% inlocal currency terms and -0.5% in US dollar terms. Forecast broadly in ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report Q3 2014 - Ghana
7/16/2014 | published by: Business Monitor International
... remain positive for the sectorwith the government's focus on domestic pharmaceutical sector, greater foreign pharmaceutical companyinterest in the country and capacity building initiatives for bringing global quality control standards toGhanaian pharmaceutical industry will spur domestic ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Morocco Q3 2014
7/11/2014 | published by: Business Monitor International
... institutions will continue to cloud the country's pharmaceutical investmentoutlook in the medium-to-long term. An unstable and inefficient regulatory environment works to create atough operating environment for drugmakers - particularly challenging in a market also characterised ...  |  read more...
USD 1,295
Healthcare Providers : Egypt
6/30/2014 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Egypt healthcare providers market. Includes market size and segmentation data, textual and ...  |  read more...
USD 350
Healthcare Providers : South Africa
6/30/2014 | published by: MarketLine
... of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa healthcare providers market. Includes market size and segmentation ...  |  read more...
USD 350
Pharmaceuticals and Healthcare Report - Egypt Q3 2014
6/18/2014 | published by: Business Monitor International
... the past few years. Key challenges facing multinational companies include a restrictive medicine pricing regime, a lack ofregulatory data protection and poor patent enforcement. Domestic companies are meanwhile impaired by aweakened currency, which restricts their ...  |  read more...
USD 1,295
Pharmaceuticals and Healthcare Report - Zimbabwe Q3 2014
6/18/2014 | published by: Business Monitor International
... Zimbabwe continues to have one of the highest Country and Industry Risks scores in the region, and thelack of foreign investment affects its ability to import significant amounts of active pharmaceuticalingredients, which are necessary for ...  |  read more...
USD 1,295
Herbal/Traditional Products - Cameroon
6/18/2014 | published by: Euromonitor International
... through networking by leading producers such as Tianshi Health Products Co, Forever Living Products and GNLD, which have popularised the benefits of such products, and branded them as 100% natural. Furthermore, herbal/traditional products are increasingly ...  |  read more...
USD 900
Pharmaceuticals and Healthcare Report - Botswana Q3 2014
6/11/2014 | published by: Business Monitor International
... healthcare aims remain a risk, as issues such as counterfeit pharmaceuticalsand expired products highlights issues in drug procurement, thereby limiting healthcare access. While Botswana offers a relatively stable environment for pharmaceutical and healthcare investors, low ...  |  read more...
USD 1,295
Sudan Pharmaceuticals and Healthcare Report Q3 2014
5/28/2014 | published by: Business Monitor International
... currency exchange rates and civilunrests are some of the key risks that will continue to limit pharmaceutical growth potential in Sudan andSouth Sudan. Headline Expenditure Projections Pharmaceuticals: SDG2.60bn (USD560mn) in 2013 to SDG3.29bn (USD540mn) in ...  |  read more...
USD 1,295
Cameroon Pharmaceuticals and Healthcare Report Q3 2014
5/28/2014 | published by: Business Monitor International
... accessibility to healthcare, tosome extent. However, we maintain that in order for Cameroon to reach its full potential, there needs to bemuch greater commitment to invest in healthcare services. Headline Expenditure Projections Pharmaceuticals: XAF148.82bn (USD300mn) ...  |  read more...
USD 1,295
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2014
5/28/2014 | published by: Business Monitor International
... to multinationals looking to launchinnovative products in Africa. This is due to risks in its pharmaceutical environment, including poor patentrespect, lack of policy enforcement and approvals expediency and a weak business setting. The healthcaremarket remains ...  |  read more...
USD 1,295
Kenya Pharmaceuticals and Healthcare Report Q3 2014
5/28/2014 | published by: Business Monitor International
... births per woman in2003 to 4.4 births per woman in 2013, we note that these figures are well above developed state fertilityrates. In 2009, the EU-27 average stood at 1.59 live births per woman. However, ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report Q3 2014
5/28/2014 | published by: Business Monitor International
... dispensing without prescriptions, sizeable 'grey markets' and thewidespread use of traditional remedies. BMI takes into account the import dependence of countries formedicines and assumes that economic growth as well as the resulting increase in the ...  |  read more...
USD 1,295
Herbal/Traditional Products in Egypt
5/22/2014 | published by: Euromonitor International
... to consumers increasingly focusing on hygiene. However, ongoing and intensifying financial pressures at the end of the review period resulted in many consumers switching from packaged products to the lower-priced loose remedies offered by herbalists. ...  |  read more...
USD 900
Herbal/Traditional Products in Nigeria
5/22/2014 | published by: Euromonitor International
... activities raised awareness and also boosted non-direct selling companies, which promoted their products in stores, building on a strong local tradition towards usage of herbal products. Thus, growth in 2013 was faster than the review ...  |  read more...
USD 900
Gabon Pharmaceuticals and Healthcare Report Q3 2014
5/21/2014 | published by: Business Monitor International
... due to poor infrastructure. Thereport confirms our view that Gabon's economic and social development lags far behind what might beimplied by the country's GDP per capita of USD15,822. However, President Omar Bongo continues toactively push ...  |  read more...
USD 1,295
Mozambique Pharmaceuticals and Healthcare Report Q3 2014
5/21/2014 | published by: Business Monitor International
... Although Mozambique currently suffers from a high burdenof diseases, with the government increasing its efforts in combating this and the help of international aid,crucial steps have been taken in ensuring better screening and vaccine development ...  |  read more...
USD 1,295
Zambia Pharmaceuticals and Healthcare Report Q3 2014
5/21/2014 | published by: Business Monitor International
... two more planned for 2014, which willbe viewed favourably by investors. However, with the government allocating only 9.9% of the total budgetto healthcare, improvements in healthcare provision will continue to be driven largely by funding ...  |  read more...
USD 1,295
Uganda Pharmaceuticals and Healthcare Report Q3 2014
5/21/2014 | published by: Business Monitor International
... the government attempts tomanage a more limited budget. Nevertheless, progress continues to be made in defeating some of thecountry's most challenging diseases, such as the recent introduction of another national vaccinationprogramme against cervical cancer. Headline ...  |  read more...
USD 1,295
Namibia Pharmaceuticals and Healthcare Report Q3 2014
5/14/2014 | published by: Business Monitor International
... the Prime Minister HageGeingob appears to be making progress in encouraging greater overseas investment in the country, withrecent talks with leaders in China aimed at improving cooperation and trade between the two countries. Such improved ...  |  read more...
USD 1,295
Angola Pharmaceuticals and Healthcare Report Q3 2014
5/14/2014 | published by: Business Monitor International
... considerable risk to its economy. The Angolanhealthcare sector will steadily expand with the aid of both government and foreign investments helping toimprove on its infrastructure. The demand for basic medicines and vaccines are high, providingopportunities ...  |  read more...
USD 1,295
Algeria Pharmaceuticals and Healthcare Report Q3 2014
5/7/2014 | published by: Business Monitor International
... which illustrates growing interest in the market and an increase in theopportunities on offer. Despite the country's large pharmaceutical market, of which patented medicinescomprise 58% of the market value, we believe multinational interest in fixed ...  |  read more...
USD 1,295
Nigeria Pharmaceuticals and Healthcare Report Q3 2014
4/30/2014 | published by: Business Monitor International
... drive the demand of medicines along with the government's goals to make healthcare more accessibleand widespread throughout the country. However, the likelihood of further divestment in the oil and gassector alongside political tensions within the ...  |  read more...
USD 1,295
South Africa Pharmaceuticals and Healthcare Report Q2 2014
4/23/2014 | published by: Business Monitor International
... and poised for high single-digitgrowth over the next decade. This quarter highlighted issues surrounding intellectual property protection,in which the Innovative Pharmaceutical Association SA (IPASA) was implicated in the leakage of draftresponse campaigning against proposed changes ...  |  read more...
USD 1,295
< prev 1    3  4  5  6  7